The Application of T.SPOT-TB Assay for Early Diagnosis of Active Tuberculosis in Chronic Kidney Disease Patients Receiving Immunosuppressive Treatment

References

• Dobler CC, McDonald SP, Marks GB. Risk of tuberculosis in dialysis patients: a nationwide cohort study. PLoS One. 2011;6(12):e29563. doi: 10.1371/journal.pone.0029563.
   PubMed Web of Science ®Google Scholar
• Al-Efraij K, Mota L, Lunny C, et al. Risk of active tuberculosis in chronic kidney disease: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2015;19(12):1493–1499. doi: 10.5588/ijtld.15.0081.
   PubMed Web of Science ®Google Scholar
• Hussein MM, Mooij JM, Roujouleh H. Tuberculosis and chronic renal disease. Semin Dial. 2003;16(1):38–44.
   PubMed Web of Science ®Google Scholar
• Segall L, Covic A. Diagnosis of tuberculosis in dialysis patients: current strategy. Clin J Am Soc Nephrol. 2010;5(6):1114–1122. doi: 10.2215/CJN.09231209.
   PubMed Web of Science ®Google Scholar
• Goletti D, Butera O, Bizzoni F, et al. Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis. J Infect Dis. 2006;194(7):984–992. doi: 10.1086/507427.
   PubMed Web of Science ®Google Scholar
• Rogerson TE, Chen S, Kok J, et al. Tests for latent tuberculosis in people with ESRD: a systematic review. Am J Kidney Dis. 2013;61(1):33–43. doi: 10.1053/j.ajkd.2012.07.019.
   PubMed Web of Science ®Google Scholar
• Ferguson TW, Tangri N, Macdonald K, et al. The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: a systematic review and meta-analysis. Transplantation 2015;99(5):1084–1091. doi: 10.1097/TP.0000000000000451.
   PubMed Web of Science ®Google Scholar
• Janssens J-P, Roux-Lombard P, Perneger T, et al. Quantitative scoring of an interferon-gamma assay for differentiating active from latent tuberculosis. Eur Respir J. 2007;30(4):722–728. doi: 10.1183/09031936.00028507.
   PubMed Web of Science ®Google Scholar
• Chee CB, Barkham TM, Khinmar KW, et al. Quantitative T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens in active and latent tuberculosis. Eur J Clin Microbiol Infect Dis. 2009;28(6):667–670. doi: 10.1007/s10096-008-0670-8.
   PubMed Web of Science ®Google Scholar
• Arenas Miras MM, Hidalgo-Tenorio C, Jimenez-Gamiz P, et al. Diagnosis of latent tuberculosis in patients with systemic lupus erythematosus: T.SPOT.TB versus tuberculin skin test. Biomed Res Int. 2014;2014:291031. doi: 10.1155/2014/291031.
   PubMed Web of Science ®Google Scholar
• Leow MK, Dalan R, Chee CB, et al. Latent tuberculosis in patients with diabetes mellitus: prevalence, progression and public health implications. Exp Clin Endocrinol Diabetes. 2014;122(9):528–532. doi: 10.1055/s-0034-1377044.
   PubMed Web of Science ®Google Scholar
• Bae W, Park KU, Song EY, et al. Comparison of the sensitivity of QuantiFERON-TB Gold In-Tube and T-SPOT.TB according to patient age. PloS One. 2016;11(6):e0156917doi: 10.1371/journal.pone.0156917.
   PubMed Web of Science ®Google Scholar
• Du F, Xie L, Zhang Y, et al. Prospective comparison of QFT-GIT and T-SPOT.TB assays for diagnosis of active tuberculosis. Sci Rep. 2018;8(1):5882.
   PubMed Web of Science ®Google Scholar
• Ribeiro S, Dooley K, Hackman J, et al. T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infect Dis. 2009;9:23doi: 10.1186/1471-2334-9-23.
   PubMed Web of Science ®Google Scholar
• Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med. 2006;174(7):736–742. doi: 10.1164/rccm.200509-1516PP.
   PubMed Web of Science ®Google Scholar
• Latorre I, De Souza-Galvao M, Ruiz-Manzano J, et al. Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children. Diagn Microbiol Infect Dis. 2009;65(3):236–246. doi: 10.1016/j.diagmicrobio.2009.07.015.
   PubMed Web of Science ®Google Scholar
• Lian G, Du F, Wu H, et al. Factors Contributing to False-Negative Enzyme-Linked Immunospot Assay for Interferon-Gamma Results in Active Tuberculosis. Clin Lab. 2017;63(4):773–779.
   PubMed Web of Science ®Google Scholar
• Hamdi H, Mariette X, Godot V, et al. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists. Arthritis Res Ther. 2006;8(4):R114.
   PubMed Web of Science ®Google Scholar
• Del Tedesco E, Roblin X, Laharie D, et al. Does anti-TNF therapy influence the performance of mycobacterium tuberculosis antigen-specific interferon-gamma assays? A French multicenter experience. Inflamm Bowel Dis. 2011;17(8):1824. doi: 10.1002/ibd.21602.
   PubMed Web of Science ®Google Scholar
• Papay P, Eser A, Winkler S, et al. Factors impacting the results of interferon-gamma release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17(1):84–90. doi: 10.1002/ibd.21427.
   PubMed Web of Science ®Google Scholar
• Song DJ, Tong JL, Peng JC, et al. Tuberculosis screening using IGRA and chest computed tomography in patients with inflammatory bowel disease: a retrospective study. J Dig Dis. 2017;18(1):23–30. doi: 10.1111/1751-2980.12437.
   PubMed Web of Science ®Google Scholar
• Latorre I, Carrascosa JM, Vilavella M, et al. Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasis. J Infect. 2014;69(6):600–606. doi: 10.1016/j.jinf.2014.07.026.
   PubMed Web of Science ®Google Scholar
• Chee CBE, KhinMar KW, Gan SH, et al. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens. Am J Respir Crit Care Med. 2007;175(3):282–287. doi: 10.1164/rccm.200608-1109OC.
   PubMed Web of Science ®Google Scholar
• Haanaes OC, Bergmann A. Tuberculosis emerging in patients treated with corticosteroids. Eur J Respir Dis. 1983;64(4):294–297.
   PubMedGoogle Scholar
• Madhi SA, Nachman S, Violari A, et al. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med. 2011;365(1):21–31. doi: 10.1056/NEJMoa1011214.
   PubMed Web of Science ®Google Scholar
• Nardell E, Churchyard G. What is thwarting tuberculosis prevention in high-burden settings? N Engl J Med. 2011;365(1):79–81. doi: 10.1056/NEJMe1105555.
   PubMed Web of Science ®Google Scholar
• Tian JY, Mei J, Gao Q. Prevention and treatment of the latent infection of mycobacterium tuberculosis and its confronting problems. Chin J Tuberc Respir Dis. 2016;39(1):8–11.
   Google Scholar